These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4254276)

  • 1. Experimental and clinical pharmacology of cardiac arrhythmias.
    Haas HH
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):173-7. PubMed ID: 4254276
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current concepts of the ionic mechanisms of cardiac arrhythmias and the possible mechanisms of action of cardiac anti-arrhythmia agents].
    Porotikov VI; Lazarev AV; Glezer GA
    Usp Fiziol Nauk; 1984; 15(3):42-63. PubMed ID: 6089463
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of cardio-active agents.
    Hayes AH
    Cardiovasc Clin; 1972; 4(3):103-18. PubMed ID: 4130206
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy of arrhythmia--its therapeutic and adverse effects].
    Nohara Y
    Nihon Rinsho; 1968 Aug; 26(8):1884-98. PubMed ID: 4888917
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-arrhythmia treatment (clinical problems, classification of anti-arrhythmia drugs and personal experience].
    Walczak F
    Kardiol Pol; 1992; 36(2):97-104. PubMed ID: 1583833
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-arrhythmia drug therapy from the pharmacologist's viewpoint].
    Méndez R
    Gac Med Mex; 1968 Jan; 98(1):13-22. PubMed ID: 4391214
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arrhythmia. Its management at the leading British center].
    Kułakowski P
    Kardiol Pol; 1992; 36(2):106-9. PubMed ID: 1583825
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological treatment of arrhythmia].
    Kuch J
    Pol Tyg Lek; 1983 Jan; 38(3):103-8. PubMed ID: 6135199
    [No Abstract]   [Full Text] [Related]  

  • 10. [The auricular tissue specialized for conduction: its importance in physiology and antiarrhythmic pharmacotherapy].
    Pastelin G; Cuevas B; Alvarado JL; Méndez R
    Gac Med Mex; 1984; 120(11-12):371-85. PubMed ID: 6152584
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part I.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):139-51. PubMed ID: 7263102
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical pharmacology of antiarrhythmic drugs.
    Adams PC; Campbell RW; Julian DG
    Cardiovasc Clin; 1984; 14(3):153-90. PubMed ID: 6722851
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
    Sulimov VA
    Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications and limitations of anti-arrhythmic drugs].
    Fica V; Panaitescu G; Mătrescu F; Popescu EA
    Med Interna (Bucur); 1971 May; 23(5):523-36. PubMed ID: 5567980
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J; Scampardonis G; Alexandrides K; González Hermosillo JA
    Arch Inst Cardiol Mex; 1972; 42(4):629-34. PubMed ID: 5073709
    [No Abstract]   [Full Text] [Related]  

  • 16. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 17. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 19. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
    Akar FG
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):930-2. PubMed ID: 20367661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of various anti-arrhythmia agents on atrioventricular conduction studied by recording of His bundle potentials in humans. Preliminary study].
    Moulin MA; Potier JC; Bernard JP; Foucault JP
    Therapie; 1973; 28(1):43-54. PubMed ID: 4731483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.